Ivan Chen
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 2
- Glutathione Transferases and Polymorphisms 1
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 1
- Co-authors
- Gregg L. Semenza (7 shared papers)Haiquan Lu (6 shared papers)Debangshu Samanta (3 shared papers)Chuanzhao Zhang (4 shared papers)Huimin Zhang (4 shared papers)John W. Bullen (2 shared papers)Xiaoshun He (1 shared paper)Wanqing Iris Zhi (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Oncotarget (2 papers)Cell Reports (2 papers)Biomedicine & Pharmacotherapy (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Ivan Chen
9 papers receiving 1.5k citations
Ivan Chen's Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 837
- Molecular Biology 1.3k
- Oncology 289
- Biotechnology 48
- Energy Engineering and Power Technology 13
Countries citing papers authored by Ivan Chen
This map shows the geographic impact of Ivan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Chen more than expected).
Fields of papers citing papers by Ivan Chen
This network shows the impact of papers produced by Ivan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Chen. The network helps show where Ivan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA Hit paper breakdown → | 2016 | 814 |
| 2 | Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype Hit paper breakdown → | 2015 | 224 |
| 3 | Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells Hit paper breakdown → | 2016 | 220 |
| 4 | 2017 | 133 | |
| 5 | 2018 | 72 | |
| 6 | 2017 | 39 | |
| 7 | 2016 | 31 | |
| 8 | 2021 | 10 | |
| 9 | The Book of Filial Duty | 2010 | 5 |
About Ivan Chen
Ivan Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Biotechnology and Developmental Neuroscience, having authored 9 papers that have together received 1.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers), MicroRNA in disease regulation (1 paper), Cancer-related Molecular Pathways (1 paper), Glutathione Transferases and Polymorphisms (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Cancer Research (837 citations), Molecular Biology (1.3k citations), Oncology (289 citations), Biotechnology (48 citations) and Energy Engineering and Power Technology (13 citations). Ivan Chen has collaborated with scholars based in United States and China. Frequent co-authors include Gregg L. Semenza, Haiquan Lu, Debangshu Samanta, Chuanzhao Zhang, Huimin Zhang, John W. Bullen, Xiaoshun He, Wanqing Iris Zhi, Edward Gabrielson and Lisha Xiang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Oncotarget, Cell Reports, Biomedicine & Pharmacotherapy and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.